Imatinib can inhibit the receptor tyrosine kinase _____, making it useful for GI Stromal Tumors (GIST)
#2
Drug of choice for EGFR T790M mutation of Non-Small Cell Lung Cancer is
#3
Which kinase inhibitor has recently been approved for rx of breast cancer (Her2 +ve) with brain mets?_____
#4
Nivolumab is used as a checkpoint inhibitor in _____ lymphoma, advanced melanoma, advanced NSCLC that is previously treated, _____ carcinoma, and advanced head and neck cancers.
#5
Osimertinib, as a third-generation EGFR inhibitor is effective against NSCLC with _____ mutation
_____ and olaparib are PARP inhibitors approved for the treatment of advanced ovarian cancer.
#8
The two chimeric antitumor monoclonal antibodies are _____ and cetuximab
#9
Antineoplastic agents extracted from the Periwinkle plant is: _____
also called Catharanthus roseus
#10
Cetuximab is a monoclonal antibody against the _____ Receptor most commonly used to treat Stage IV colorectal cancer
Targeted Therapy Indian Medical PG Flashcards - Medical Study Cards
Master Targeted Therapy with OnCourse flashcards. These spaced repetition flashcards are designed for medical students preparing for NEET PG, USMLE Step 1, USMLE Step 2, MBBS exams, and other medical licensing examinations.
Targeted Therapy Flashcard Deck - 10 Cards
Flashcard 1: Imatinib can inhibit the receptor tyrosine kinase _____, making it useful for GI Stromal Tumors (GIST)
Answer: c-Kit
Flashcard 2: Drug of choice for EGFR T790M mutation of Non-Small Cell Lung Cancer is
Answer: Osimertinib
Flashcard 3: Which kinase inhibitor has recently been approved for rx of breast cancer (Her2 +ve) with brain mets?_____
Answer: Tucatinib
Flashcard 4: Nivolumab is used as a checkpoint inhibitor in _____ lymphoma, advanced melanoma, advanced NSCLC that is previously treated, _____ carcinoma, and advanced head and neck cancers.
Answer: Hodgkin's; renal cell
Flashcard 5: Osimertinib, as a third-generation EGFR inhibitor is effective against NSCLC with _____ mutation
Flashcard 7: _____ and olaparib are PARP inhibitors approved for the treatment of advanced ovarian cancer.
Answer: Rucaparib
Flashcard 8: The two chimeric antitumor monoclonal antibodies are _____ and cetuximab
Answer: rituximab
Flashcard 9: Antineoplastic agents extracted from the Periwinkle plant is: _____
also called Catharanthus roseus
Answer: Vinca alkaloids
Flashcard 10: Cetuximab is a monoclonal antibody against the _____ Receptor most commonly used to treat Stage IV colorectal cancer
Answer: EGF
Keywords: Targeted Therapy flashcards, medical flashcards, NEET PG preparation, USMLE Step 1 flashcards, Anki alternative, spaced repetition medical, OnCourse flashcards
Targeted Therapy Flashcards for NEET-PG
Study 10 flashcards on Targeted Therapy for NEET-PG Pharmacology. These active recall cards cover the key concepts, clinical associations, and high-yield facts from this chapter of Anticancer Drugs. Each card is designed to test your understanding rather than just recognition, building stronger and more durable memories for exam day.
For personalised spaced repetition scheduling and unlimited flashcards, download the Oncourse app.
Frequently Asked Questions
Are Targeted Therapy flashcards free?
Yes, all flashcards on this page are completely free. You can study all 10 cards at no cost. For spaced repetition scheduling, download the Oncourse app.
How many flashcards does this chapter have?
There are 10 flashcards for Targeted Therapy, covering the key concepts, clinical correlations, and high-yield facts from this chapter of Anticancer Drugs.
How should I use these flashcards for NEET-PG?
Read through each prompt and try to answer before revealing the back of the card. This active recall approach builds stronger memories than passive reading. Combine flashcards with the study notes and MCQ practice for the best results.
Are there more flashcards for Anticancer Drugs?
Yes. This page covers one chapter of Anticancer Drugs. Visit the topic page to see all chapters and their flashcards under Pharmacology.
Want unlimited flashcards?
Get full access to all flashcards, spaced repetition, and progress tracking.